We are live on ! Find out more
ICVX

Icosavax, Inc. Common Stock

Delisted

ICVX was delisted on the 16th of February, 2024.

73 hedge funds and large institutions have $101M invested in Icosavax, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

556% more call options, than puts

Call options by funds: $59K | Put options by funds: $9K

320% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 5

28% more funds holding

Funds holding: 5773 (+16)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

23% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 22

46% less capital invested

Capital invested by funds: $188M → $101M (-$86.8M)

Holders
73
Holders Change
+16
Holders Change %
+28.07%
% of All Funds
1.26%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
21
Increased
17
Reduced
22
Closed
5
Calls
$59K
Puts
$9K
Net Calls
+$50K
Net Calls Change
+$75K
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$18.8M
QUSVM
2
Qiming U.S. Ventures Management
Washington
$11.1M
ASP
3
Adams Street Partners
Illinois
$10.7M
Fidelity Investments
4
Fidelity Investments
Massachusetts
$10.5M +$1.5M +240,494 +8%
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$10.5M +$20.7M +3,315,060 New
PIM
6
Platinum Investment Management
Australia
$5.95M +$1.56M +249,764 +15%
Citadel Advisors
7
Citadel Advisors
Florida
$5.35M +$788K +126,026 +8%
BlackRock
8
BlackRock
New York
$4.78M -$150K -23,961 -2%
N
9
NanoDimension
California
$4.3M -$2.34M -374,256 -22%
Vanguard Group
10
Vanguard Group
Pennsylvania
$2.62M -$19.5K -3,113 -0.4%
RSCM
11
Rock Springs Capital Management
Maryland
$2.47M +$122K +19,443 +3%
LCM
12
Laurion Capital Management
New York
$2.35M
CAM
13
Cormorant Asset Management
Massachusetts
$2.03M -$47.3K -7,568 -1%
State Street
14
State Street
Massachusetts
$1.42M +$517K +82,635 +22%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$1.16M +$190K +30,390 +9%
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$1.01M
Citigroup
17
Citigroup
New York
$1.01M +$1.41M +225,276 +239%
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$782K +$529K +84,499 +52%
UBS Group
19
UBS Group
Switzerland
$553K -$96.2K -15,378 -8%
Northern Trust
20
Northern Trust
Illinois
$526K -$11.3K -1,813 -1%
BCM
21
Bridgeway Capital Management
Texas
$373K +$738K +118,052 New
PA
22
Perceptive Advisors
New York
$296K -$5.94M -949,259 -91%
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$234K +$20.3K +3,245 +5%
N
24
Nuveen
North Carolina
$226K -$5.38K -860 -1%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$205K +$43.6K +6,972 +12%

ICVX Hedge Fund Activity: Q3 2022 in Review

73 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q3 2022, worth a combined $101M — down 46% from $188M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ICVX positions and 5 closed out — a net gain of 16 holders — while 17 added to existing stakes and 22 trimmed.

The largest buyer was Platinum Investment Management, adding an estimated $1.56M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $19.2M sold.

  • 73 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q3 2022, up from 57 in Q2 2022.
  • Funds reported $101M of Icosavax, Inc. Common Stock stock for Q3 2022, down 46% quarter-over-quarter.
  • 21 funds opened new Icosavax, Inc. Common Stock positions in Q3 2022 and 5 closed out, a net change of +16 holders.
  • The largest Icosavax, Inc. Common Stock buyer in Q3 2022 was Platinum Investment Management, an estimated $1.56M added.
  • The largest Icosavax, Inc. Common Stock seller in Q3 2022 was T. Rowe Price Associates, an estimated $19.2M sold.

Based on aggregated 13F filings for Q3 2022.